Welcome to our Evotec Blog.

Hope you will find our articles and resources relevant for your projects and interests.

Our experts are available for any additional information and to assist with your project challenges!

Just contact us.

 

 

2017

How de-risking strategies in API development can improve efficiencies and increase chances of success
Stephen Gorsuch, 20 February 2017

Managing the risks of your Active Pharmaceutical Ingredient (API) strategy Drug development is a risky venture, to say the least. With a proportionally small number of potential leads making it through even to clinical trials, de-risking is an important step in any API strategy. There can be a plethora of routes to taking a drug through the...

Steps before undertaking Active Pharmaceutical Ingredient (API) synthesis
Colin Lindley, 5 February 2017

Before API synthesis begins Drug development begins with the synthesis of the API itself, so it will come as no surprise that this stage is critical to any development program. Ensuring prompt API delivery is a good step in the right direction of a successful drug development project. Timelines for drug development programs are often based on...

 

 

Contact us

Evotec

Business Development

T +44.(0)1235.86 15 61 T +1.732 329 2355 x3308